Price
$274.41-5.96%Social Signal Score
Analyst Ratings
39 analysts52-week range
- Last close
- $274.41
- Off 52w high
- -11.8%
- 200-day average
- $278.71
- vs 200-day
- -1.5%
Revenue
$71.67B+625.38%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Brian C. Evanko
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Employees
- 66,685
- Beta
- 0.32
- Country
- US
- Piotroski score
- 8 / 9 (Strong)
- Altman Z-score
- 2.76
Financials
Revenue
$71.67B+625.4%Net Income
$1.66B+264.0%EBITDA
$2.61B+185.9%Free Cash Flow
$-718.00M-140.6%EPS (diluted)
$6.29+257.4%Shares Outstanding (diluted)
263.96M+1.6%Operating Expenses
$3.47BCash & Debt
$6.30BReturn of Capital
$689.00MRevenue by Segment (annual)
$282.37BDividend per Share
$1.56Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $274.95B | $5.96B | $22.30 |
| 2024 | $247.12B | $3.43B | $12.25 |
| 2023 | $195.26B | $5.16B | $17.57 |
| 2022 | $180.52B | $6.70B | $21.66 |
| 2021 | $174.07B | $5.37B | $15.89 |
| 2020 | $160.40B | $8.46B | $23.17 |
| 2019 | $153.57B | $5.10B | $13.58 |
| 2018 | $48.65B | $2.64B | $10.69 |
| 2017 | $41.81B | $2.24B | $9.17 |
| 2016 | $39.84B | $1.87B | $7.31 |
| 2015 | $37.88B | $2.09B | $8.17 |
| 2014 | $34.91B | $2.10B | $7.97 |
| 2013 | $32.38B | $1.48B | $5.28 |
| 2012 | $29.12B | $1.62B | $5.70 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CI's reported EPS growth of 11.1% a year over 13 years.
- EPS in 5 years
- $37.91
- Implied price
- $454.97
- Return from $270.53
- 11.0% a year
To earn 15.0% a year on these assumptions you'd need to buy at $226.20 — -16.4% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 8 | 10 | 12 | 14 | 16 |
|---|---|---|---|---|---|
| 1.1% | -6.9% | -2.6% | 1.0% | 4.1% | 6.9% |
| 6.1% | -2.3% | 2.2% | 6.0% | 9.3% | 12.2% |
| 11.1% | 2.3% | 7.0% | 11.0% | 14.4% | 17.5% |
| 16.1% | 6.9% | 11.8% | 16.0% | 19.6% | 22.8% |
| 21.1% | 11.5% | 16.6% | 20.9% | 24.7% | 28.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
174+55.60%Social Signal Score
Mentions (34)
- News (RSS)seekingalpha·4d ago·Positive
Cigna: Deeply Undervalued With Expected Double-Digit EPS Growth Ahead
View source ↗ - Newsseekingalpha.com·5d ago·Positive
Cigna: Deeply Undervalued With Expected Double-Digit EPS Growth Ahead Cigna is rated a 'Strong Buy' for its compelling value, robust earnings growth, and capital returns at a forward P/E of 8.9x. CI posted strong Q2 2026 results, raised full-year EPS guidance, and targets 10–14% annual EPS growth through 2030, driven by AI and specialty pharmacy. CI's asset-light model, expanding specialty pharma presence, and aggressive share buybacks support high-teens total return potential annually.
View source ↗ - News (RSS)seekingalpha·5d ago·Positive
The Cigna Group (CI) Analyst/Investor Day Transcript
View source ↗ - Newsseekingalpha.com·5d ago·Positive
The Cigna Group (CI) Analyst/Investor Day Transcript The Cigna Group (CI) Analyst/Investor Day Transcript
View source ↗ - Newsmarketbeat.com·5d ago·Neutral
Cigna Reaffirms 2026 Outlook, Targets Complex Care and AI-Driven Growth Cigna Group NYSE: CI reaffirmed its 2026 outlook and outlined a long-term strategy centered on complex care, technology-enabled personalization and disciplined capital deployment at its 2026 Investor Day.
View source ↗ - News (RSS)forbes·5d ago·Neutral
Cigna To Ramp Up Investments In Specialty Pharmacy And Complex Care Cigna is ramping up investments in specialty pharmacy and a companywide focus into better ways to manage complex care of patients in its health plans.
View source ↗ - Newsprnewswire.com·6d ago·Neutral
…financial growth target of 10-14% adjusted EPS CAGR through 2030 BLOOMFIELD, Conn., Sept. 30, 2026 /PRNewswire/ -- Today, at its Investor Day, The Cigna Group (NYSE: CI) will outline its strategy to improve affordability and personalization across the health care continuum.
View source ↗ - Newsbarrons.com·6d ago·Negative
Cigna Stock in Focus as Investor Day Spotlights Specialty Drugs Cigna Group investors will be looking for more detail on the growth of its specialty pharmacy business under new CEO Brian Evanko.
View source ↗ - Newsetftrends.com·14d ago·Positive
Defying Headwinds, the U.S. Economy Continues to Flex Its Resilience We believe that there is nothing more fundamental and reflective of economic health than the employment situation, and the latest data reflects an economy showing persistent growth. After July's disappointing payroll print, the August employment report rebounded strongly.
View source ↗ - Newszacks.com·17d ago·Neutral
Can Cigna's AI Push Help Rein In Rising Healthcare Costs? CI is expanding AI across care coordination and specialty pharmacy as it seeks to manage elevated healthcare costs and improve access.
View source ↗ - News (RSS)forbes·22d ago·Neutral
Is The Health Insurer Rebound Complete? Some Seem To Think So An increasing number of industry analysts say costs are under control for the likes of CVS Health, Centene, Cigna, Elevance Health, Humana, UnitedHealth Group and others.
View source ↗ - News (RSS)zerohedge·25d ago·Neutral
…into AI engineering could increase their average salary from $145,000 to $230,000, adding about $85,000 to their annual pay. Existing programming, system design, and CI/CD experience remains valuable, while additional skills include LLM orchestration, RAG pipelines, and AI agent frameworks. The transition takes an estimated four to eight months, and nearly 1,000 job postings were identified. AI product managers earn an estimated $210,000 annually, compared with $135,000 for traditional product m…
View source ↗ - Newsprnewswire.com·26d ago·Negative
SMiT unveils UWB-enabled CI+ 2.0 dongle and Presence-Aware TV platform at IBC2026 /PRNewswire/ -- SMiT, a global provider of secure TV-access hardware and solutions, will unveil its Presence-Aware TV platform anchored by a CI+ 2.0 USB dongle
View source ↗ - 4chan /biz/biz·26d ago·Positive
Can you beat GPT's portfolio >Adobe >MU >NVDA >AVGO >META >TSMC Lockheed >Leonardo > SAP >Shell >BHP >Cigna
View source ↗ - Newsprnewswire.com·27d ago·Neutral
The Cigna Group to Host Investor Day on September 30 BLOOMFIELD, Conn., Sept. 9, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) will host its Investor Day on Wednesday, September 30, 2026.
View source ↗ - Newszacks.com·35d ago·Positive
Here's Why Cigna (CI) is a Strong Value Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
View source ↗ - Newszacks.com·39d ago·Neutral
Can Cigna's Smart Coverage Help Close Health-Cost Gaps? CI's Smart Coverage links medical and supplemental benefits, offering up to $7,000 and automated claims for costly health events.
View source ↗ - Newsetftrends.com·40d ago·Positive
Beneath the Headlines: An Economy in Transition, Not in Trouble Key Takeaways The July jobs report headline (-23,000 payrolls and a combined -103,000 in prior-month revisions) glances over a more nuanced picture: layoffs remain historically low and job openings remain plentiful. This looks like a labor-supply problem, not a demand setback.
View source ↗ - Newsprnewswire.com·41d ago·Neutral
…employers more affordable coverage options BLOOMFIELD, Conn., Aug. 26, 2026 /PRNewswire/ -- Cigna Healthcare®, the health benefits division of The Cigna Group (NYSE: CI), is introducing a new connected benefits experience that helps people pay for costs associated with unexpected or costly health events by bringing medical and supplemental health benefits together in a simpler, more personalized way.
View source ↗ - Newszacks.com·42d ago·Neutral
5 HMO Stocks to Watch Amid Steady Premium Flow, Increased Digitization An aging U.S. population, digital transformation, a diversified membership mix and strategic M&A are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
View source ↗ - Newszacks.com·42d ago·Positive
Cigna (CI) is a Top-Ranked Growth Stock: Should You Buy? Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - News (RSS)financialpost·45d ago·Neutral
CI Global Asset Management Announces Monthly Cash Distributions for August 2026 for Certain CI ETFs NOT FOR DISSEMINATION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO — CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending August 31, 2026 for ETFs managed by CI GAM with a payment date of September 3, 2026. The payment will be […]
View source ↗ - News (RSS)venturebeat·46d ago·Neutral
…so quick wasn't there — and we've effectively knocked all of that down."Wang went further, sketching where he believes this ends up. Toil work — "fixing bugs, fixing CI/CD, or fixing vulnerabilities, all these things engineers probably don't want to do — we think will be automated away," he said. What remains is the work that "requires creativity, planning, business logic." He added a prediction that will make some engineering leaders uneasy: while a human still gates every merge today, "I suspe…
View source ↗ - News (RSS)financialpost·47d ago·Negative
CI Global Asset Management Announces Special Reinvested Distribution for CI Alternative Investment Grade Credit Fund ETF Series TORONTO — CI Global Asset Management (“CI GAM”) announces the following special reinvested distribution for CI Alternative Investment Grade Credit Fund ETF Series (TSX: CRED, CRED.U). The special reinvested distribution will be reinvested on August 21, 2026, to unitholders of record on August 20, 2026. The special reinvested distribution will not be paid in cash, […]
View source ↗ - News (RSS)fool·47d ago·Positive
CI&T (CINT) Q2 2026 Earnings Call Transcript Revenue hit $142.8M with 21.9% organic growth as AI-focused verticals accelerated.
View source ↗ - Newszacks.com·47d ago·Positive
Here's Why Investors Should Stay Neutral on Cigna Stock for Now CI's growth and shareholder returns are weighed against rising costs, medical expenses and debt, keeping investors neutral for now.
View source ↗ - Newsglobenewswire.com·47d ago·Neutral
…ops Corporate Insight’s 2026 Brokerage Website Benchmark, Ties with Charles Schwab for Mobile Lead New York, NY, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Corporate Insight (CI), the leading provider of competitive intelligence and customer experience research to the financial services, insurance and healthcare industries, today announced the leaders in its 2026 Brokerage Website Experience Benchmark and 2026 Brokerage Mobile Experience Benchmark, evaluating the websites and mobile apps of 21 leading br…
View source ↗ - News (RSS)venturebeat·49d ago·Neutral
…ts, issues and the API, and near 50% on archive and raw file downloads, according to GitHub's incident log. Enterprise single sign-on went down with it: SAML, OIDC, SCIM provisioning and Team Sync all failed. So did Copilot.The developer internet did what the developer internet does."You can now host your repos in Cursor Origin and deploy to Vercel via Cursor Origin which is itself hosted on Vercel," Vercel chief executive Guillermo Rauch posted on X. "And unlike GitHub, it's online 😁" Asked wh…
View source ↗ - News (RSS)venturebeat·49d ago·Positive
…y downtime, latency, or a data inconsistency as by a bad note, and some of our highest-leverage work is invisible, including canary releases with automatic rollback, CI gates on database changes, and cross-region consistency checks. Clinician trust is the product, and trust is architectural.”Sponsored articles are content produced by a company that is either paying for the post or has a business relationship with VentureBeat, and they’re always clearly marked. For more information, contact sales…
View source ↗ - News (RSS)seekingalpha·49d ago·Positive
Cigna: I'm Buying What Others Are Ignoring
View source ↗ - Newsseekingalpha.com·50d ago·Positive
Cigna: I'm Buying What Others Are Ignoring Cigna Group remains a "Buy," with double-digit adjusted EPS growth intact and shares trading 28% below fair value. CI's Accredo and AI-powered Pharmacy Forward platforms are key growth drivers, supporting robust revenue and margin expansion through 2028. The company boasts an A- S&P credit rating, strong free cash flow, and a secure, growing dividend with low payout ratios.
View source ↗ - 4chan /biz/biz·54d ago·Negative
>>62587494 claude is so f****** trash for actual real jobs, man the rest of the AI scams are trash too the entire AI industry is propped up by executives and investors being wooed and impressed by email summaries and can't even begin to comprehend how terrible they perform in real world applications just the other day my company's entire CI/CD pipeline got raped because management-mandated "agentic mergeflow" generated d****** batch scripts and kept ramming it into the build containers which
View source ↗ - News (RSS)financialpost·55d ago·Neutral
Copenhagen Infrastructure Partners’ large-scale BESS project Coalburn 1 reaches commercial operation Coalburn 1, a 500 MW, two-hour duration battery energy storage system in Scotland, is now the largest operational battery in Europe. COPENHAGEN, Denmark, Aug. 12, 2026 (GLOBE NEWSWIRE) — Copenhagen Infrastructure Partners (CIP), through its flagship fund Copenhagen Infrastructure IV (CI IV), is pleased to announce that Coalburn 1 has commenced commercial operations. Coalburn 1 […]
View source ↗ - News (RSS)seekingalpha·55d ago·Neutral
CI&T Inc. 2026 Q2 - Results - Earnings Call Presentation
View source ↗
Earnings
Thu, Oct 29(in 3 weeks)
Consensus estimate $7.51 per share
Typical surprise +2.5% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Jul 30$7.78 vs $7.60beat
- Thu, Apr 30$7.79 vs $7.60beat
- Thu, Feb 5$8.08 vs $7.88beat
- Thu, Oct 30$7.83 vs $7.64beat
- Thu, Jul 31$7.20 vs $7.16beat
- Fri, May 2$6.74 vs $6.35beat
Estimates and results for CI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CI officers and directors.
- Bought
- —
- Sold
- $65.7m
0 trades
17 trades
- Neville Everettsold
- Jones Nicole Ssold
- Jones Nicole Ssold
- Kates Jamie Gsold
- Cordani Davidsold
- Cordani Davidsold
- Cordani Davidsold
- Cordani Davidsold
83 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Julie Johnsonhouse · TX32 · disclosed Aug 6, 2026 (317d later)Buy$1,001 - $15,000
- Julie Johnsonhouse · TX32 · disclosed Aug 6, 2026 (317d later)Sell$1,001 - $15,000
- Alan Armstrongsenate · disclosed Jul 21, 2026 (116d later)Buy$1,001 - $15,000
- Jared Moskowitzhouse · FL23 · disclosed May 1, 2026 (39d later)Sell$1,001 - $15,000
- Jared Moskowitzhouse · FL23 · disclosed May 1, 2026 (39d later)Sell$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA31 · disclosed Apr 8, 2026 (26d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Feb 10, 2026 (28d later)Buy$1,001 - $15,000
- Julie Johnsonhouse · TX32 · disclosed Jan 16, 2026 (29d later)Sell$1,001 - $15,000
- Julia Letlowhouse · LA05 · disclosed Jan 13, 2026 (447d later)Buy$1,001 - $15,000
- Julia Letlowhouse · LA05 · disclosed Jan 13, 2026 (266d later)Sell$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA31 · disclosed Jan 12, 2026 (24d later)Buy$1,001 - $15,000
- Gilbert Ray Cisneroshouse · CA31 · disclosed Dec 15, 2025 (33d later)Sell$1,001 - $15,000
- Julie Johnsonhouse · TX32 · disclosed Dec 12, 2025 (29d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 14, 2025 (15d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 14, 2025 (15d later)Sell$1,001 - $15,000
- Val Hoylehouse · OR04 · disclosed Oct 10, 2025 (17d later)Sell$1,001 - $15,000
- Julie Johnsonhouse · TX32 · disclosed Oct 8, 2025 (13d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 3, 2025 (4d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 3, 2025 (28d later)Buy$1,001 - $15,000
- Val Hoylehouse · OR04 · disclosed Sep 12, 2025 (318d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.